Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.38−0.01 (-3.53%)
Close on Nov 12, 2026Market cap $5.67MP/E –Yield –
Tempest Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Tempest Therapeutics's operating margin for the twelve months ending Sep 30, 2018 was -20266.7%. For fiscal 2017 it was -28585.1%, against -12406.1% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -28585.1% | −16179.0 |
| FY2016 | Dec 31, 2016 | -12406.1% | +13586.3 |
| FY2015 | Dec 31, 2015 | -25992.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2018 | Sep 30, 2018 | -14192.7% | +2603.7 |
| Q2 FY2018 | Jun 30, 2018 | -6155.6% | +15189.7 |
| Q1 FY2018 | Mar 31, 2018 | -6549.3% | +16604.7 |
| Q4 FY2017 | Dec 31, 2017 | -46597.8% | −28111.9 |
| Q3 FY2017 | Sep 30, 2017 | -16796.4% | −7170.0 |
| Q2 FY2017 | Jun 30, 2017 | -21345.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -23154.0% | – |
| Q4 FY2016 | Dec 31, 2016 | -18486.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -9626.4% | – |
See a number that looks wrong?